• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SMARTFREEZE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SMARTFREEZE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Lot Number SFA00667
Medical Device Problem Code Increase in Pressure (1491)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/05/2024
Type of Reportable Event Malfunction
Event or Problem Description
During an atrial fibrillation ablation procedure, a smartfreeze was selected for use.It was reported that the error 1 - 00000020-2: outer balloon pressure is too high was displayed during case.Troubleshooting performed, the cryo-cable disconnect/reconnect, replacement of cryo-cable and balloon, power cycle.No defects observed in the catheter.The procedure was canceled.No patient complications occurred.The device has been returned for analysis.This event is being reported due to procedure cancellation while the patient was under general sedation.
 
Event or Problem Description
During an atrial fibrillation ablation procedure, a smartfreeze was selected for use.It was reported that the error 1 - (b)(4): outer balloon pressure is too high was displayed during case.Troubleshooting performed, the cryo-cable disconnect/reconnect, replacement of cryo-cable and balloon, power cycle.No defects observed in the catheter.The procedure was canceled.No patient complications occurred.The device has been returned for analysis.This event is being reported due to procedure cancellation while the patient was under general sedation.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory this device was analyzed.The returned sv9 was connected to test console and outer balloon pressure rapidly increased resulting in error 1: (b)(4).The outer balloon pressure is too high during the inflation state.The sv9 was examined, and a white crystalline debris was found on the plunger.This crystalline debris contained elevated levels of sulfur, butyl zimate and zinc stearate.The white fiber was found to be consistent to teflon tape.This failure is addressed under capa-00007933: smartfreeze console sv9 solenoid valve obp failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTFREEZE
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112 5798
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18895452
Report Number2124215-2024-14993
Device Sequence Number6189256
Product Code OAE
UDI-Device Identifier08714729992691
UDI-Public08714729992691
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Lot NumberSFA00667
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/13/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/21/2024
Supplement Date Received by Manufacturer05/01/2024
Initial Report FDA Received Date03/13/2024
Supplement Report FDA Received Date05/23/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/08/2023
Is the Device Labeled for Single Use? (Y/N) No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-